Suzanne King is investigating  risk factors for schizophrenia, such as prenatal stress, obstetric complications, and cannabis use.

Claire-Dominique Walker investigates the consequences of early stress on brain development and the neuroendocrine responses to stress.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

Florian Storch explores explores the biological role of circadian clocks, internal timers that generate rhythms  of 24 hours.

Work from Rémi Quirion's lab has helped to characterize the roles of cholinergic synapses in Alzheimer Disease, neuropeptide Y in depression and learning, and calcitonin gene-related peptide (CGRP) in pain and opioid tolerance.

Researchers examining the “Mood, Anxiety, and Impulsivity-related Disorders” theme are aiming to identify the genetic , psychological, neurobiological and environmental causes of most mood disorders and testing the most effective treatments. Their main focus is on: Depression Bipolar disorder Personality disorders Post-traumatic stress disorder Eating disorders Substance dependence, e.g. drug or alcohol Suicide Identifying risk factors and responding ef...

The researchers exploring the “Schizophrenia and neurodevelopmental disorders” theme focus on the causes, course, treatment and prevention of: Schizophrenia and other psychotic disorders Attention deficit hyperactivity disorder (ADHD), conduct disorder, oppositional defiant disorder and Gilles de la Tourette syndrome Autism (research and evaluation) In Canada, one in a hundred people will be diagnosed with schizophrenia while 3 to 5% of children have an attention deficit...

A 2007 lecture by Serge Gauthier, MD, on Alzheimer's disease (in French).

 A new study published by the team of Naguib Mechawar sheds enven more light on depression.

Dr Rosa-Neto's work is among projects awarded new funds by CQDM, Brain Canada and the Ontario Brain Institute (OBI).